Publications by authors named "A Aranda Arrufat"
Article Synopsis
- This study examined the effects of two antiviral treatments, remdesivir and nirmatrelvir/ritonavir, on hematological patients infected with SARS-CoV-2 during the Omicron period, using data from a Spanish registry collected from December 2021 to April 2023.
- Out of 466 patients analyzed, those treated with nirmatrelvir/ritonavir had a low COVID-19-related mortality rate of 1.3%, primarily used in mild cases, while remdesivir, used for moderate to severe cases, showed a higher mortality rate of 9%.
- The study found that male gender was linked to lower mortality risk while corticosteroid use and co-infections increased risk, and highlighted that
